The global incretin-based drugs market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2022-2028). Increased research activity, government initiatives to promote disease awareness, and research grants are primary factors which are expected to fuel the global incretin-based drug market’s growth over the forecast period. Furthermore, rising government spending in R&D activities, […]
